1. Corporate Officers - W
2. Worland Stephen T

Insider Trading History of Worland Stephen T

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Worland Stephen T since 2006. This trader's CIK number is 1283307. At the time of last reporting, Worland Stephen T was the Chief Executive Officer of Effector Therapeutics, Inc.. (stock ticker symbol EFTR). Also see all insider trading activities at Effector Therapeutics, Inc..

Note that in the past WORLAND STEPHEN T also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Worland Stephen T

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2008	ANDS	0	$0	0	$0	33,898	$99,999
2007	ANDS	150,000	$305,981	0	$0	25,000	$73,750
2006	ANDS	0	$0	7,000	$106,000	0	$0

Yearly summary of insider trading at Effector Therapeutics, Inc. (EFTR) by Worland Stephen T

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	EFTR	0	$0	0	$0	33,799	$17,575
2022	EFTR	20,000	$27,400	0	$0	0	$0

Insider trading activities at 2 companies by Worland Stephen T:

1. Anadys Pharmaceuticals Inc (ANDS)

2. Effector Therapeutics, Inc. (EFTR)

Table 1. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Worland Stephen T

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2008-05-30	ANDS	Option Ex	33,898	2.95	99,999
2007-09-04	ANDS	Buy	13,236	2.35	31,038
2007-08-31	ANDS	Buy	12,200	2.12	25,815
2007-08-30	ANDS	Buy	124,564	2.00	249,128
2007-01-12	ANDS	Option Ex	25,000	2.95	73,750
2006-03-16	ANDS	Sale	4,000	16.00	64,000
2006-03-02	ANDS	Sale	3,000	14.00	42,000

Table 2. Insider trading of Effector Therapeutics, Inc. (EFTR) by Worland Stephen T

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-08-11	EFTR	Option Ex	33,799	.52	17,575
2022-06-07	EFTR	Buy	20,000	1.37	27,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Worland Stephen T (Chief Executive Officer of Effector Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month